Ultragenyx reports preliminary 2025 revenue of $672-674 million

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/4/2026

1. CRWD
2. AVGO
3. VEEV
4. FIVE
5. PLTR
6. NTSK
7. SPY
8. AI
9. VRTS
10. MDT

Go back to Ultragenyx reports preliminary 2025 revenue of $672-674 million
ULTRAGENYX PHARM (NASDAQ: RARE) Delayed: 23.30 +0.89 (3.97%)
Previous Close $22.41    52 Week High $117.12 
Open $22.51    52 Week Low $46.52 
Day High $23.47    P/E N/A 
Day Low $22.18    EPS $-1.97 
Volume 455,559